P16INK4a Immunohistochemistry in cervical biopsy specimens a systematic review and meta-analysis of the interobserver agreement

American Journal of Clinical Pathology

Volumn 142, Issue 6, 2014, Pages 767-772

  Reuschenbach, Miriam ^a   Wentzensen, Nicolas ^b   Dijkstra, Maaike G ^c   Von Knebel Doeberitz, Magnus ^a   Arbyn, Marc ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Agreement; Cervical intraepithelial neoplasia; Histopathology; P16INK4A; Reproducibility

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EOSIN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; META ANALYSIS; PRIORITY JOURNAL; PUNCH BIOPSY; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; OBSERVER VARIATION; UTERINE CERVICAL NEOPLASMS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84922333872     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP3TPHV4TRIZEK     Document Type: Article

References (29)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
2. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(suppl 10):K1-K16.
3. Rodriguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102:315-324.
4. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
5. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:368-383.
6. Castle PE, Gage JC, Wheeler CM, et al. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstet Gynecol. 2011;118:1222-1229.
7. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol. 2008;9:425-434.
8. Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113:18-25.
9. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516-542.
10. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
11. Stoler MH, Vichnin MD, Ferenczy A, et al. The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer. 2011;128:1354-1362.
12. Bergeron C, Ordi J, Schmidt D, et al. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2010;133:395-406.
13. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337:a1284.
14. Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2008;17:2536-2545.
15. von Knebel Doeberitz M, Reuschenbach M, Schmidt D, et al. Biomarkers for cervical cancer screening: The role of p16INK4a to highlight transforming HPV infections. Expert Rev Proteomics. 2012;9:149-163.
16. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley; 1981.
17. Harris R, Bradburm M, Deeks J, et al. metan: fixed- And random-effects meta-analysis. Stata J. 2008;8:3-26..
18. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. Ann Intern Med. 2009;151:264-269, W64.
19. Lee S, Kim H, Kim H, et al. The utility of p16INK4a and Ki-67 as a conjunctive tool in uterine cervical lesions. Korean J Pathol. 2012;46:253-260.
20. Horn LC, Reichert A, Oster A, et al. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2008;32:502-512.
21. Omori M, Hashi A, Nakazawa K, et al. Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types. Am J Clin Pathol. 2007;128:208-217.
22. Yang QC, Liu HB, Zhu Y, et al. Expression of ProEXC, p16 and Ki-67 in cervical intraepithelial lesion by immunohistochemistry: diagnostic and clinical significance [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2012;41:405-407.
23. Sayed K, Korourian S, Ellison DA, et al. Diagnosing cervical biopsies in adolescents: The use of p16 immunohistochemistry to improve reliability and reproducibility. J Low Genit Tract Dis. 2007;11:141-146.
24. Yang QC, Zhu Y, Liou HB, et al. A cocktail of MCM2 and TOP2A, p16INK4a and Ki-67 as biomarkers for the improved diagnosis of cervical intraepithelial lesion. Pol J Pathol. 2013;64:21-27.
25. Galgano MT, Castle PE, Atkins KA, et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34:1077-1087.
26. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399.
27. Gurrola-Diaz CM, Suarez-Rincon AE, Vazquez-Camacho G, et al. p16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. Gynecol Oncol. 2008;111:120-124.
28. Dijkstra MG, Heideman DA, de Roy SC, et al. p16INK4a immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol. 2010;63:972-977.
29. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205-242.